FDA Guarded About Regulatory Routes For Distal Protection Devices For SVGs
This article was originally published in The Gray Sheet
Executive Summary
FDA has indicated that despite the 510(k) submission by Medtronic/PercuSurge for the GuardWire distal protection device for saphenous vein graft repair, future regulatory process decisions will be done on a case by case basis.
You may also be interested in...
Boston Sci Sees Clinical Uptake Of Wallstent, Filterwire For Carotid Use
Both components of Boston Scientific's carotid angioplasty system will be approved for different indications by the end of the year, by which time patient enrollment for the firm's SHELTER carotid stent trial is expected to be complete.
Boston Sci Sees Clinical Uptake Of Wallstent, Filterwire For Carotid Use
Both components of Boston Scientific's carotid angioplasty system will be approved for different indications by the end of the year, by which time patient enrollment for the firm's SHELTER carotid stent trial is expected to be complete.
Boston Scientific Gains Distal Protection Market Entry With EPI's Filterwire
Boston Scientific's $75 mil. acquisition of Embolic Protection, Inc. provides an immediate entry into the vascular distal protection market.